Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007879
Filing Date
2022-05-05
Accepted
2022-05-05 16:32:35
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20220331.htm   iXBRL 10-Q 1522358
2 EX-31.1 tyra-ex31_1.htm EX-31.1 20457
3 EX-31.2 tyra-ex31_2.htm EX-31.2 20708
4 EX-32.1 tyra-ex32_1.htm EX-32.1 11418
5 EX-32.2 tyra-ex32_2.htm EX-32.2 11395
  Complete submission text file 0000950170-22-007879.txt   5539791

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20220331.xsd EX-101.SCH 44047
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tyra-20220331_def.xml EX-101.DEF 150732
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20220331_lab.xml EX-101.LAB 372492
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20220331_pre.xml EX-101.PRE 266937
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tyra-20220331_cal.xml EX-101.CAL 33676
50 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20220331_htm.xml XML 851235
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 22896931
SIC: 2834 Pharmaceutical Preparations